TMCnet News
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, to Participate in Upcoming November Investor ConferencesSOUTH SAN FRANCISCO, Calif. and LIBERTY CORNER, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Marea Therapeutics, Inc. (“Marea”), a subsidiary of Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”), a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced that management will participate in the following investor conferences: Guggenheim Healthcare Innovation Conference LifeSci Growth and Innovation Summit Jefferies Global Healthcare Conference London Live webcasts of the presentations at the GuggenheimHealthcare Innovation Conference and the Jefferies Global Healthcare Conference London will be available on the “Events & Presentations” section within the Investors page on the Lisata website. Replays of the webcasts will be available following each event. About Marea Therapeutics About Lisata Therapeutics Contacts: Lisata: Investors and Media: Marea: Media: Investors:
|

